Newly onset cytopenias not always indicate a relapsing AML after allogeneic HSCT, a case of non-destructive post transplant lymphoproliferative disorder

Newly onset cytopenias not always indicate a relapsing AML after allogeneic HSCT, a case of non-destructive post transplant lymphoproliferative disorder

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains an effective option for the treatment of intermediate and high-risk Acute myeloid leukemia (AML). Post-transplant lymphoproliferative disorder (PTLD) is related to the intensity of post-transplant immunosuppression. Although Epst...

Full description

Bibliographic Details
Main Authors: Süreyya Yiğit Kaya, Abdullah Emre Askin, Sebnem Bektas, Aslı Çakır, Ömür Gökmen Sevindik
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Leukemia Research Reports
Subjects:
Acute myeloid leukemia
Post transplant lymphoproliferative disorder
Epstein-Barr virus
Rituximab
Online Access:http://www.sciencedirect.com/science/article/pii/S2213048923000092

Internet

http://www.sciencedirect.com/science/article/pii/S2213048923000092

Similar Items